AGM results

RNS Number : 9121W

Epistem Holdings plc

26 November 2010

 

Epistem Holdings Plc

26^th November 2010

Epistem Plc (LSE: EHP), the rapidly growing UK biotechnology and Personalised Medicine company announces today that all resolutions at the Annual General Meeting held on 24 November 2010 were passed.

Epistem Plc
Matthew Walls	Chief Executive Officer	[phone]
John Rylands	Finance Director	[phone]
KBC Peel Hunt Ltd
James Steel		[phone]
Vijay Barathan		[phone]
De Facto Communications
Mike Wort / Anna Dunphy		[phone]

Notes to Editors:

About Epistem

Epistem is a biotechnology and Personalised Medicine company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal diseases and dermatological applications. Epistem develops innovative therapeutics, biomarkers and diagnostics and provides contract research services to drug development companies. The Group's expertise is focused on the regulation of adult stem cells located in epithelial tissue, which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. The Company was originally formed in 2000 and this year celebrates its 10 year anniversary.

Epistem operates three distinct business divisions, Contract Research Services, Novel Therapies and Personalised Medicine (biomarker and diagnostics). 

 

END

 

 

RAGUNSVRRBAAUAA